These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9135274)

  • 21. Altered chloride ion channel kinetics associated with the delta F508 cystic fibrosis mutation.
    Dalemans W; Barbry P; Champigny G; Jallat S; Dott K; Dreyer D; Crystal RG; Pavirani A; Lecocq JP; Lazdunski M
    Nature; 1991 Dec 19-26; 354(6354):526-8. PubMed ID: 1722027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic analysis of cystic fibrosis in Pakistan: a preliminary report.
    Bhutta ZA; Moattar T; Shah U
    J Pak Med Assoc; 2000 Jul; 50(7):217-9. PubMed ID: 10992696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype and genotype of two Taiwanese cystic fibrosis siblings and a survey of delta F508 in East Asians.
    Lin CJ; Chang SP; Ke YY; Chiu HY; Tsao LY; Chen M
    Pediatr Neonatol; 2008 Dec; 49(6):240-4. PubMed ID: 19166122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel, mechanism-based therapies for cystic fibrosis.
    Rubenstein RC
    Curr Opin Pediatr; 2005 Jun; 17(3):385-92. PubMed ID: 15891431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do delta F508 heterozygotes have a selective advantage?
    Wiuf C
    Genet Res; 2001 Aug; 78(1):41-7. PubMed ID: 11556136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygotes for the delta F508 cystic fibrosis allele are not protected against bronchial asthma.
    Mennie M; Gilfillan A; Brock DJ; Liston WA
    Nat Med; 1995 Oct; 1(10):978-9. PubMed ID: 7489375
    [No Abstract]   [Full Text] [Related]  

  • 27. [Frequency of mutations and genotypes of the CFTR gene in cystic fibrosis adults in Poland].
    Witt M; Pogorzelski A; Bal J; Rutkiewicz E; Majka L; Sobczyńska A
    Pneumonol Alergol Pol; 1999; 67(3-4):137-41. PubMed ID: 10497446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microsatellite haplotypes of Polish cystic fibrosis alleles: delta F508 chromosomes demonstrate a North-South haplotype frequency gradient.
    Witt M; Reis A; Cichy W; Dziechciowska K
    Hum Hered; 1996; 46(6):310-4. PubMed ID: 8956026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New approaches to cystic fibrosis.
    Moss RB
    Hosp Pract (1995); 2001 Jan; 36(1):25-7, 31-2, 35-7. PubMed ID: 11197941
    [No Abstract]   [Full Text] [Related]  

  • 30. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cystic fibrosis lung disease and its management].
    Hidaka N; Hidaka Y
    Nihon Rinsho; 1999 Sep; 57(9):2139-44. PubMed ID: 10497420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synonymous codon usage affects the expression of wild type and F508del CFTR.
    Shah K; Cheng Y; Hahn B; Bridges R; Bradbury NA; Mueller DM
    J Mol Biol; 2015 Mar; 427(6 Pt B):1464-1479. PubMed ID: 25676312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic fibrosis: bench to bedside 2003.
    Rubin BK
    Can Respir J; 2003 Apr; 10(3):161-4. PubMed ID: 12712228
    [No Abstract]   [Full Text] [Related]  

  • 34. Dysfunction of CFTR bearing the delta F508 mutation.
    Welsh MJ; Denning GM; Ostedgaard LS; Anderson MP
    J Cell Sci Suppl; 1993; 17():235-9. PubMed ID: 7511616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis as a disease of misprocessing of the cystic fibrosis transmembrane conductance regulator glycoprotein.
    Riordan JR
    Am J Hum Genet; 1999 Jun; 64(6):1499-504. PubMed ID: 10330337
    [No Abstract]   [Full Text] [Related]  

  • 36. Severe cystic fibrosis phenotype in a delta F508/3272-26A-->G compound heterozygote.
    Bienvenu T; Beldjord C; Kaplan JC; Hubert D; Dusser D
    J Med Genet; 1995 Nov; 32(11):919. PubMed ID: 8592345
    [No Abstract]   [Full Text] [Related]  

  • 37. New pharmaceutical approaches to the treatment of cystic fibrosis.
    Delaney SJ; Wainwright BJ
    Nat Med; 1996 Apr; 2(4):392-3. PubMed ID: 8597941
    [No Abstract]   [Full Text] [Related]  

  • 38. Cystic fibrosis transmembrane conductance regulator-mRNA delivery: a novel alternative for cystic fibrosis gene therapy.
    Bangel-Ruland N; Tomczak K; Fernández Fernández E; Leier G; Leciejewski B; Rudolph C; Rosenecker J; Weber WM
    J Gene Med; 2013; 15(11-12):414-26. PubMed ID: 24123772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mismatch cleavage detects base deletion in cystic fibrosis gene.
    Hsu IC; Highsmith WE; Xu J; Kong D
    Biotechniques; 1998 Oct; 25(4):692-6. PubMed ID: 9793654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An abnormal distribution of delta F508 genotypes in cystic fibrosis patient registries.
    Feingold J; Guilloud-Bataille M; De Crozes D
    Ann Genet; 1998; 41(1):31-3. PubMed ID: 9599649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.